Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin

By Peternel P.   Terbizan M.   Tratar G.   Bozic M.   Horvat D.   Salobir B.   Stegnar M.  

Thrombosis Research, Vol. 105, Iss. 3, 2002-02 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis

By Chong Beng   Brighton Tim   Baker Ross   Thurlow Peter   Lee Choon  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 3, 2005-06 ,pp. : 173-181

Springer Publishing Company

Access to resources Recommend Favorite

Platelet scintigraphy results of heparin versus streptokinase treatment in acute deep vein thrombosis

By Silistreli Erdem   Bekis Recep   Serbest Onur   Arslan Gulhan   Ulker Ozden   Catalyurek Hudai   Acikel Unal  

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 6, 2004-12 ,pp. : 380-382

Informa Healthcare

Access to resources Recommend Favorite

Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin

By Ulander V.-M.   Lehtola A.   Kaaja R.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 239-242

Elsevier

Access to resources Recommend Favorite

An update on the Management and Treatment of Deep Vein Thrombosis

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 4, 2011-10 ,pp. : 207-217

Bentham Science Publishers

Access to resources Recommend Favorite